Cryopreserved Umbilical Cord Allograft

Phase 3Biologic

Cryopreserved Umbilical Cord Allograft is one of 11 biologic programs targeting Prostatectomy. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ProstatectomyRecruiting

ProstatectomyPhase 3

Recruiting

Competition

Competitive Landscape

11 competitors in Prostatectomy

#DrugCompanyPhaseTrials

Leuprorelin

Takeda

Phase 3

1 2

Sutent

Pfizer

Phase 2

1 3

Firmagon

Ferring

Phase 2

3 4

LHRH Agonist

Roche

Phase 2

2 5

Cryopreserved Umbilical Cord Allograft

HHackensack Meridian Health

Phase 3

1 6

Flomax

Sanofi

Preclinical

1 7

Ramosetron

Astellas

Preclinical

1 8

ARN-509

AAragon Pharmaceuticals, Inc.

Phase 2

1 9

Vesicare

Astellas

Preclinical

2 10

Acetaminophen/ibuprofen

SSeoul National University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 2/3Recruiting

Prostatectomy

NCT04263025

Clinical

Trials by Indication[1]

Prostatectomy1 trial

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

Recruiting·HHackensack Meridian Health·Phase 2/3·NCT04263025·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Cryopreserved Umbilical Cord Allograft. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cryopreserved Umbilical Cord Allograft compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cryopreserved Umbilical Cord Allograft. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hackensack Meridian Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 3[1]
Company: HHackensack Meridian Health

Cryopreserved Umbilical Cord Allograft

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Prostatectomy1 trial

References

Drug Info

Quick Facts

Related News